Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;19(1):68-75.
doi: 10.4048/jbc.2016.19.1.68. Epub 2016 Mar 25.

Oncologic Safety of Immediate Breast Reconstruction for Invasive Breast Cancer Patients: A Matched Case Control Study

Shin-Hoo Park  1 , Wonshik Han  2 , Tae-Kyung Yoo  1 , Han-Byoel Lee  1 , Ung Sik Jin  3 , Hak Chang  3 , Kyung Won Minn  3 , Dong-Young Noh  2
Affiliations

Oncologic Safety of Immediate Breast Reconstruction for Invasive Breast Cancer Patients: A Matched Case Control Study

Shin-Hoo Park et al. J Breast Cancer. 2016 Mar.

Abstract

Purpose: The purpose of this study was to compare locoregional recurrence-free survival (LRFS) and disease-free survival (DFS) between patients undergoing mastectomy and immediate breast reconstruction (IBR) and those undergoing mastectomy alone.

Methods: A retrospective review of patients who underwent mastectomy and immediate breast reconstruction for resectable invasive breast cancer between 2002 and 2010 at a single center was conducted. These cases were matched to patients who underwent mastectomy alone in the same time period, performed by 1:2 matching. Matching control variables included age, tumor size, axillary lymph node metastasis, and estrogen receptor status. Overall, 189 patients were identified in the IBR group, and 362 patients were matched to this group.

Results: In the IBR group, 75 patients (39.7%) underwent conventional total mastectomy, 78 (41.3%) underwent skin-sparing mastectomy (SSM), and 36 (19.0%) underwent nipple-sparing mastectomy (NSM). The IBR group was significantly younger than the control group (41.9 and 45.1 years, respectively) (p=0.032), in spite of matching between three age groups. The DFS rates were similar between the IBR group and mastectomy alone group, at 92.0% and 89.9%, respectively, at 5-year follow-up (log-rank test, p=0.496). The 5-year LRFS was 96.2% in the IBR group and 96.4% in the mastectomy alone group (log-rank test, p=0.704), similar to data from previous reports. Subgroup analyses for SSM or NSM patients showed no differences in LRFS and DFS between the two groups. Additionally, in stage III patients, IBR did not cause an increase in recurrence.

Conclusion: IBR after mastectomy, including both SSM and NSM, had no negative impact on recurrence or patient survival, even in patients with advanced disease.

Keywords: Locoregional neoplasm recurrence; Mammaplasty; Mastectomy; Matched case-control study.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST: The authors declare that they have no competing of interests.

Figures

Figure 1
Figure 1. Recurrence-free survival in all patients. (A) Disease-free survival in the immediate reconstruction group (n=189) and the mastectomy alone group (n=362). (B) Locoregional recurrence-free survival in the immediate reconstruction group (n=189) and the mastectomy alone group (n=362).
IBR=immediate breast reconstruction.
Figure 2
Figure 2. Recurrence-free survival in skin-sparing mastectomy (SSM) or nipple-sparing mastectomy (NSM) group. (A) Disease-free survival in the immediate reconstruction group with SSM or NSM group (n=114) and a matched control group (n=191). (B) Locoregional recurrence-free survival in the immediate reconstruction group undergoing either SSM or NSM (n=114) and a matched control group (n=191).
IBR=immediate breast reconstruction.
Figure 3
Figure 3. Recurrence-free survival in patients with stage III cancer. (A) Disease-free survival in the immediate reconstruction group with stage III cancer (n=22) and a matched control group (n=43). (B) Locoregional recurrence-free survival in the immediate reconstruction group with stage III cancer (n=22) and a matched control group (n=43).
IBR=immediate breast reconstruction.
See this image and copyright information in PMC

References

    1. Liang TJ, Wang BW, Liu SI, Yeh MH, Chen YC, Chen JS, et al. Recurrence after skin-sparing mastectomy and immediate transverse rectus abdominis musculocutaneous flap reconstruction for invasive breast cancer. World J Surg Oncol. 2013;11:194. - PMC - PubMed
    1. Drucker-Zertuche M, Robles-Vidal C. A 7 year experience with immediate breast reconstruction after skin sparing mastectomy for cancer. Eur J Surg Oncol. 2007;33:140–146. - PubMed
    1. van Mierlo DR, Lopez Penha TR, Schipper RJ, Martens MH, Serroyen J, Lobbes MB, et al. No increase of local recurrence rate in breast cancer patients treated with skin-sparing mastectomy followed by immediate breast reconstruction. Breast. 2013;22:1166–1170. - PubMed
    1. Kim Z, Min SY, Yoon CS, Jung KW, Ko BS, Kang E, et al. The basic facts of Korean breast cancer in 2012: results from a nationwide survey and breast cancer registry database. J Breast Cancer. 2015;18:103–111. - PMC - PubMed
    1. Romics L, Jr, Chew BK, Weiler-Mithoff E, Doughty JC, Brown IM, Stallard S, et al. Ten-year follow-up of skin-sparing mastectomy followed by immediate breast reconstruction. Br J Surg. 2012;99:799–806. - PubMed

LinkOut - more resources